Role of Interleukin- (IL-) 17 in the Pathogenesis and Targeted Therapies in Spondyloarthropathies
Spondyloarthropathy (SpA) is a unique type of joint inflammation characterized by coexisting erosive bone damage and pathological new bone formation. Previous genetic association studies have demonstrated that several cytokine pathways play a critical role in the pathogenesis of ankylosing spondylit...
Main Authors: | I-Tsu Chyuan, Ji-Yih Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2018-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2018/2403935 |
Similar Items
-
Role of interleukin-17 in the pathogenesis of rheumatoid arthritis
by: Jeffrey A Ongkowijaya, et al.
Published: (2018-02-01) -
Genetic and Environmental Determinants of T Helper 17 Pathogenicity in Spondyloarthropathies
by: Davide Simone, et al.
Published: (2021-09-01) -
Criteria and application of biologic therapies for Spondyloarthropathy
by: André José Mendonça Vieira
Published: (2019) -
Is Interleukin 17 (IL-17) Expression A Common Point in the Pathogenesis of Depression and Obesity?
by: Katarzyna Bliźniewska-Kowalska, et al.
Published: (2020-12-01) -
INTERLEUKIN 1A GENE POLYMORPHISMS IN ROMANIAN PATIENTS WITH SERONEGATIVE SPONDYLOARTHROPATHIES
by: Laura Ioana Cherciu, et al.
Published: (2016-03-01)